New drug approval pathway benefits industry over patients, argues expert
Peer-Reviewed Publication
Updates every hour. Last Updated: 12-Jun-2026 21:16 ET (13-Jun-2026 01:16 GMT/UTC)
Ten medical students from Boston University Chobanian & Avedisian School of Medicine were recognized recently by the Massachusetts Medical Society (MMS) at its 17th Annual Research Poster Symposium, which was held in conjunction with its signature education event, Future Health: Best Practices for Advancing Care.
This year, symposium participants competed in four different categories: clinical research, basic research, clinical vignettes, and health policy/medical education. Eight posters were accepted in these categories out of a field of more than 120 abstract entries. Three winners were selected in each category, and several honorable mentions were awarded.
The American Association for Public Opinion Research presented the Annenberg Public Policy Center this month with the 2026 Policy Impact Award for the Annenberg Science and Public Health survey.
An early warning system for sepsis, one of the deadliest infections for hospital patients, has been approved for use by the FDA, one of the first AI-based medical tools to get clearance.
The tool, developed by Johns Hopkins University researchers and now commercialized by Bayesian Health, detects sepsis hours faster than doctors and has reduced deaths by nearly 20%.